What is the current Price Target for the 4D Molecular Therapeutics Inc stock?

The average 4D Molecular Therapeutics Inc target price is $36.20. This is 511.49% higher than the current stock price. The highest price target is 1,116.22%, the lowest is 1.35%. 10 Analysts have issued a price target 4D Molecular Therapeutics Inc 2026 .

How high will the 4D Molecular Therapeutics Inc stock rise?

No reliable answer can be given as to how high the 4D Molecular Therapeutics Inc stock will rise. The performance of stocks, including the 4D Molecular Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the 4D Molecular Therapeutics Inc stock today?

The performance of 4D Molecular Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the 4D Molecular Therapeutics Inc stock fall?

The decline in 4D Molecular Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

4D Molecular Therapeutics Inc Forecast, price target & analysts

$6.08

2.65% today

Nasdaq, Feb 05, 07:19 pm CET

ISIN

US35104E1001

Symbol

FDMT

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

4D Molecular Therapeutics Inc Target price 2025 - Analyst rating & recommendation

4D Molecular Therapeutics Inc Classifications & Recommendation:

Buy

73%

Hold

18%

Sell

4D Molecular Therapeutics Inc Price Target

Target Price	$36.20
Price	$5.92
Potential	511.49% register free of charge
Number of Estimates	10

	10 Analysts have issued a price target 4D Molecular Therapeutics Inc 2026 . The average 4D Molecular Therapeutics Inc target price is $36.20. This is 511.49% register free of charge higher than the current stock price. The highest price target is $72.00 1,116.22% register free of charge , the lowest is $6.00 1.35% register free of charge .
	A rating was issued by 11 analysts: 8 Analysts recommend 4D Molecular Therapeutics Inc to buy, 2 to hold and 1 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the 4D Molecular Therapeutics Inc stock has an average upside potential 2026 of 511.49% register free of charge . Most analysts recommend the 4D Molecular Therapeutics Inc stock at Purchase.

Discover more stocks with a high price target

Uber Technologies 28.24%

BYD 28.04%

Porsche 27.62%

PayPal 24.21%

Tencent Holdings Ltd. 23.67%

Microsoft 23.34%

Alibaba Group Holding Ltd 19.22%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now

The Apple stock at a glance with charts, current key metrics, news and stock analyses.

The Best Dividend Stocks in the Dividend Top Scorer list.

Stock Analyses of the Best Stocks Worldwide.

Start building wealth today